Our research into skeletal muscle regeneration is focused on the use of protein-based therapeutics – an emerging class of biologics designed to closely mimic the body’s natural compounds. Unlike traditional small-molecule drugs, these biologics are large, complex molecules that offer highly targeted and potentially more effective treatments.
In 2021, Myostellar Co-founders Prof. Peter Currie and A/Prof. Mikaël Martino released their revolutionary reasearch on the regeneration of muscle stem cells. These findings are the scientific discovery that led to the formation of Myostellar.
A group of genetic diseases that gradually cause the muscles to degenerate, leading progressive muscle weakness and loss of muscle mass. Duchenne muscular dystrophy is the most frequently occurring and one of the most severe forms of the muscular dystrophies.
The loss of muscle mass which can be caused by a range of factors including aging, disuse, medications, injuries and diseases.
